Exposure to excessive alcohol disrupts the activity of a protein that plays a key role in keeping liver fat healthy,…
Articles by Marisa Wexler, MS
A gene-editing therapy designed to specifically inactivate a hidden genetic blueprint of the hepatitis B virus (HBV) — the cause…
One year of treatment with saroglitazar, Zydus Therapeutics’ experimental oral candidate, outperformed a placebo at normalizing markers of liver…
Babies who had standard Kasai surgery when they were more than 60 days old or had spleen malformations were more…
A one-hour point-of-care test for hepatitis C has been cleared for use in Canada, which could help accelerate diagnosis…
The U.S. Food and Drug Administration (FDA) has conditionally approved Novo Nordisk’s Wegovy (semaglutide) to treat certain people with…
India’s Central Drugs Standard Control Organization has approved the oral therapy nor-ursodeoxycholic acid (NorUDCA) for people with metabolic dysfunction-associated steatotic…
A new artificial intelligence (AI) algorithm can help identify babies with genetic forms of cholestasis, including progressive familial intrahepatic…
The proportion of cases of hepatocellular carcinoma (HCC) attributable to fatty liver disease is set to rise in the…
A new study has uncovered a key mechanism behind the liver scarring seen in biliary atresia (BA), a rare…